Hussman Strategic Advisors, Inc. Ptc Therapeutics, Inc. Transaction History

Hussman Strategic Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 31, 2019	SELL	$35.42 - $45.0 $1.77 Million - $2.25 Million	-50,000 Closed	0 $0
Q4 2018 Feb 01, 2019	BUY	$29.83 - $46.51 $447,450 - $697,650	15,000 Added 42.86%	50,000 $1.72 Million
Q3 2018 Oct 31, 2018	SELL	$33.9 - $47.77 $508,500 - $716,550	-15,000 Reduced 30.0%	35,000 $1.65 Million
Q2 2018 Jul 31, 2018	BUY	$25.7 - $47.88 $1.29 Million - $2.39 Million	50,000 New	50,000 $1.69 Million

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.24B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Hussman Strategic Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Hussman Strategic Advisors, Inc. with notifications on news.